Resource Library
If you do not find the information you are looking for, email us at sales@indevr.com or give us a call at +1 303-402-9100.
VaxArray® Portfolio
Brochures
- Expert Services Brochure
- mRNA Brochure
- OmniFlu HA Brochure
- VaxArray Brochure
- VaxArray Overview Video
Application Notes
- Stability Indicating
- Crude In-Process Samples
- Quantification of Neuraminidase in Vaccines
- Compatibility with Adjuvanted Vaccines
- VaxArray Measles and Rubella Assay Correlation to CCID50
- D-Antigen ELISA Replacement for Polio
Webinars/Video
- Vaccine Development: Multiplexed Solutions on the InDevR VaxArray Platform
- Innovating Vaccine Development: The role of VaxArray in SolaVAX, a novel photochemical inactivation vaccine platform
- Innovating Vaccine Development: The role of VaxArray in SolaVAX, a novel photochemical inactivation vaccine platform
- InDevR Booster – Multiplexed, Rapid VaxArray Immunoassay for Neuraminidase Vaccine Antigen Characterization
- Speed and Simplicity for mRNA Vaccines and Therapeutics CQA Testing
- Assessing Neuraminidase Presence in Influenza Vaccines Using InDevR’s VaxArray Platform
- Streamline mRNA Vaccine Development with Rapid Multiplexed Potency Tests
- Standardizing and Streamlining Vaccine Antigen Quantification for Polio, Measles, & Rubella
- Upgrade Your Vaccine Development and Bioprocess Optimization by Replacing Laborious ELISA, SRID, or TCID50
- 10 min Introduction video to VaxArray for Coronavirus
- Accelerating Development of COVID-19 Vaccines Using InDevR’s Novel VaxArray Coronavirus SeroAssay
- A Novel Method for Antigen Characterization of Measles And Rubella Vaccines
- Highly Multiplexed, 30-minute VaxArray Assay for Pneumococcal Vaccine Antigen Characterization
Publications
- 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen
- Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses
- Kentucky BioProcessing: Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle
- Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma
- Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing
- Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses
- A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
- Hemagglutinin and neuraminidase potency testing of influenza vaccines
- Potency assay for rapid assessment of pandemic influenza vaccines
- Assessment of influenza split vaccine potency and stability
- VaxArray Immunoassay for the Multiplexed Quantification of Poliovirus D-Antigen
Posters
- VaxArray Measures 24 Pneumococcal Vaccine Antigens in Less Than One Hour
- Vaxess – InDevR: Quantitation of Influenza HA from the MIMIX Vaccine Patch by VaxArray System
- A Novel Tool to Enable Multivalent Vaccine Development for Influenza and Coronavirus
- Seasonal Influenza Assessment of Adjuvanted Vaccines
- Assessment of Cell-Derived Influenza Vaccine Potency
- Assessment of Influenza Vaccine Potency and Stability
